AVTX
NASDAQ · Biotechnology
Avalo Therapeutics Inc
$15.23
-0.24 (-1.55%)
Analyst Consensus
Strong Buy
21
Analysts
High
Coverage
Price Target
Analyst Price Target
+116.1% upside
Low Target
$27.78
Average Target
$32.91
High Target
$47.11
Current Price
$15.23
Current
$15.23
$15.23
Target
$32.91
$32.91
$27.78
$32.91 avg
$47.11
Scenario Analysis
Bear Case
$27.78
82.4%
Low target
Base Case
$32.91
+116.1%
Avg target
Bull Case
$47.11
+209.3%
High target
Risk/Reward
2.5x
Favorable
Price in Context
52-Week High
$24.27
-37.2% from high
52-Week Low
$10.70
+42.3% from low
Target vs 52W High
$32.91
+35.6% vs high
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 39 | 82% | $257.58 | -3.3% |
| AMGN | Hold | 43 | 47% | $190.87 | -54.4% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +138.3% |
| VRTX | Strong Buy | 36 | 81% | $438.34 | -16.9% |
| REGN | Buy | 38 | 68% | $76.80 | -89.8% |
| MRNA | Hold | 30 | 37% | $149.45 | -24.2% |
| NTRA | Strong Buy | 30 | 87% | $142.91 | -65.3% |
| RVMD | Strong Buy | 28 | 93% | $114.11 | -43.4% |